PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35288308-0	2022	alpha-Hederin inhibits the platelet activating factor-induced metastasis of HCC cells through disruption of PAF/PTAFR axis cascaded STAT3/MMP-2 expression.	beta-hederin	0-13	platelet activating factor receptor	Homo sapiens	112-117	
35288308-0	2022	alpha-Hederin inhibits the platelet activating factor-induced metastasis of HCC cells through disruption of PAF/PTAFR axis cascaded STAT3/MMP-2 expression.	beta-hederin	0-13	signal transducer and activator of transcription 3	Homo sapiens	132-137	
35288308-0	2022	alpha-Hederin inhibits the platelet activating factor-induced metastasis of HCC cells through disruption of PAF/PTAFR axis cascaded STAT3/MMP-2 expression.	beta-hederin	0-13	matrix metallopeptidase 2	Homo sapiens	138-143	
35288308-8	2022	Moreover, we demonstrated alpha-Hederin reduced the PAF-induced matrix metalloproteinase-2 expression through inhibiting the activation of STAT3 in PAF stimulated HCC cells.	beta-hederin	26-39	signal transducer and activator of transcription 3	Homo sapiens	139-144	
35288308-9	2022	These findings suggest that alpha-Hederin functions as a prospective inhibitor of PTAFR and may be utilized as an optional candidate for treatment of HCC.	beta-hederin	28-41	platelet activating factor receptor	Homo sapiens	82-87